Back Pain News and Research RSS Feed - Back Pain News and Research

Back pain is a very common problem affecting almost all individuals at some point in their lives. Back pain most commonly affects the lower back although it can be felt anywhere along the spine. An individual may experience aching, tension and stiffness that lasts for only a few days or weeks, or these symptoms may continue for many months or even years.

In most cases, back pain does not have a specific or serious cause and is often referred to as 'non-specific' pain. However, the pain can be triggered or worsened by, for example, a poor sitting or standing posture or bending or lifting incorrectly.

The use of painkillers and keeping active is often sufficient for the condition to resolve within 12 weeks. If back pain lasts longer than this, in which case it is termed chronic pain, an individual should visit their doctor. If the back pain is accompanied by any one of a fever, unexplained weight loss, swelling in the back, chest pain, leg pain, loss of bladder or bowel control, inability to pass urine, or pain that is worse at night, then medical help should be sought immediately. These are termed 'red flag symptoms' and could be a sign of something more serious such as rheumatoid arthritis, a slipped disc or osteoporosis.

People can reduce their chance of developing back pain by engaging in regular exercise, particularly swimming or walking, taking care to bend from the knees and hips rather than the back and maintaining a good posture.
Covered California unveils ad campaign, awards $14.6M for outreach

Covered California unveils ad campaign, awards $14.6M for outreach

And new enrollment numbers for that state show a growing individual insurance market, officials said. Meanwhile, a Nebraska woman recounts her experience as a navigator, and Oregon officials say a tax credit error will affect fewer people than expected. [More]
Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Eli Lilly and Company today announced that the RAISE trial, a Phase III study of ramucirumab (CYRAMZA) in combination with chemotherapy in patients with metastatic colorectal cancer (mCRC), met its primary endpoint of overall survival. [More]
Study provides new recommendations for men with lower back pain

Study provides new recommendations for men with lower back pain

A study using motion capture technology provides new information on the spinal strain produced by various sexual positions-suggesting that one position commonly recommended for all men with low back pain is not actually the best choice, reports a study in the journal Spine. [More]
Groundbreaking study reveals best positions to save spine during and after sex

Groundbreaking study reveals best positions to save spine during and after sex

Contrary to popular belief, spooning is not always the best sex position for those with a bad back, according to new research from the University of Waterloo. [More]
USF receives FEMA grant to reduce risk of low back pain, disability in firefighters

USF receives FEMA grant to reduce risk of low back pain, disability in firefighters

The University of South Florida's John Mayer, DC, PhD, recently received a $1.3 million Department of Homeland Security/Federal Emergency Management Agency Assistance of Firefighters grant - a three-year award that will help build upon cumulative research evaluating the effectiveness of targeted exercise programs to reduce the risk of low back pain and disability in firefighters. [More]
Study to measure and estimate global ablation market

Study to measure and estimate global ablation market

Reportbuyer.com has added a new market research report: Ablation Devices: Technologies and Global Markets. [More]
Decision tool set to improve management of low back pain

Decision tool set to improve management of low back pain

Experts have developed an evidence-based tool to help doctors in secondary and tertiary care decide how best to manage patients with chronic low back pain, a condition with the highest societal burden in Western Europe. [More]
Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Janssen Research & Development, LLC and its development partner, Bayer HealthCare, announced today the expansion of the EXPLORER global cardiovascular research program for XARELTO (rivaroxaban) to include additional high-risk patient populations. [More]
Study: Young athletes need to avoid continuous repetitive activity to decrease risk of pars fracture

Study: Young athletes need to avoid continuous repetitive activity to decrease risk of pars fracture

Young athletes today often participate in sports year round and with increasingly competitive club and school sports, it has become common to choose one sport to specialize at a young age. While this specialization may seem like a competitive edge, new Northwestern Medicine research suggests that repetitive activity in just one sport, high impact or not, may not be a great idea for growing athletes. [More]
Doctor offers four important benefits of laser back surgery

Doctor offers four important benefits of laser back surgery

The spinal column is one of the most delicate and essential areas of the human body. Signals carried to and from the brain through the column control many key functions of our motor skills and nervous system. [More]
CEOLIVE.TV interviews BioElectronics expert as part of its Executive Interview Series

CEOLIVE.TV interviews BioElectronics expert as part of its Executive Interview Series

BioElectronics Corporation, the maker of advanced consumer medical devices said that its EVP Dr. Deepak Kotak was interviewed by CEOLIVE.TV as part of its Executive Interview Series. [More]
Physical activity fails to show link with chronic musculoskeletal pain

Physical activity fails to show link with chronic musculoskeletal pain

Neither little nor excessive physical activity contributes to chronic musculoskeletal pain in people who are middle-aged or older, Japanese study findings suggest. [More]
Study reports rising prevalence of chronic opioid use by SSDI recipients

Study reports rising prevalence of chronic opioid use by SSDI recipients

More than 40 percent of Social Security Disability Insurance recipients take opioid pain relievers, while the prevalence of chronic opioid use is over 20 percent and rising, reports a study in the September issue of Medical Care. [More]
PSAL students to receive free comprehensive health screening at HSS

PSAL students to receive free comprehensive health screening at HSS

It's a parent's worst nightmare, and it happens out of the blue. While playing a sport, often football, a teen athlete collapses on the field and doesn't make it. [More]
Disabling back pain increases mortality risk for older women

Disabling back pain increases mortality risk for older women

Disabling back pain puts women in their 70s at an increased risk of death, findings from the Cambridge City over-75s Cohort study suggest. [More]
Research reveals that seizures linked to feelings of anxiety

Research reveals that seizures linked to feelings of anxiety

New research by clinical psychologists from the UK and US has revealed psychogenic seizures which could be mistaken for epilepsy are linked to feelings of anxiety. [More]
GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

GSK today announced that once-weekly Tanzeum (albiglutide), a prescription injectable treatment for type 2 diabetes in adults, as an adjunct to diet and exercise, is now available in pharmacies throughout the U.S. [More]
Longer looks: the economics of infertility; placebos as treatment raises ethical dilemmas

Longer looks: the economics of infertility; placebos as treatment raises ethical dilemmas

About a decade ago, Medicaid programs were struggling to keep up with skyrocketing prescription drug costs. Between 1997 and 2002, drug spending in the program for low-income Americans grew by about 20 percent annually. ... Medicaid directors began looking for ways to tamp down on those costs. One of the most popular policies was something called "prior authorization" for a new wave of more expensive, anti-psychotic drugs ,... These policies, in a sense, worked: they helped rein in how much Medicaid spent filling prescriptions. But in another sense, they may not have worked at all: a growing body of research has begun questioning whether restricting drug spending may have just shifted costs elsewhere -; particularly, into the prison system (Sarah Kliff, 7/22). [More]
Paracetamol fails to beat placebo at relieving back pain

Paracetamol fails to beat placebo at relieving back pain

Paracetamol is no more effective than placebo at relieving acute lower back pain, according to new clinical trial results. [More]
FDA approves Targiniq ER to treat severe pain

FDA approves Targiniq ER to treat severe pain

Today, the U.S. Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), an extended-release/long-acting (ER/LA) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. [More]